Table 1.
Characteristics of HIV-infected homeless and marginally housed adults reporting prescription drug coverage and receiving antiret-roviral therapy
| Variable N (%) or Mean/Median ± SD | Study population N = 125 | Medicare Part D covered N = 44 | Other drug coverage N = 81 | Testa |
|---|---|---|---|---|
| Demographic | ||||
| Biologic sex | ||||
| Male | 87 (69.6%) | 38 (86.4%) | 49 (60.5%) | 9.02** |
| Race/Ethnicity | ||||
| White | 43 (34.4%) | 22 (50.0%) | 21 (25.9%) | |
| African-American | 50 (40.0%) | 15 (34.1%) | 35 (43.2%) | |
| Other | 32 (25.6%) | 7 (15.9%) | 25 (30.9%) | 7.89* |
| Age at baseline | ||||
| Mean years | 43.3 ± 8.0 | 45.2 ± 8.7 | 42.3 ± 7.4 | −1.96* |
| Income | ||||
| Median | 892 ± 12.3 | 923.0 ± 205.0 | 846.0 ± 92.0 | 3.78* |
| Housing Status | ||||
| Homeless in the past year | 111 (88.8%) | 39 (88.6%) | 72 (88.9%) | <0.01 |
| Clinical status and health care utilization | ||||
| CD4 nadir mean | 215 ± 189 | 219 ± 183 | 213 ± 194 | −0.16 |
| CD4 count mean | 406 ± 308 | 434 ± 355 | 392 ± 281 | −0.68 |
| Viral Load—suppressed | 76 (60.8%) | 28 (66.7%) | 48 (62.3%) | 2.24 |
| SF-36 physical composite score mean | 40.8 ± 11.1 | 39.5 ± 12.3 | 41.5 ± 10.5 | 0.98 |
| Beck depression inventory severity scale mean | 12.5 ± 10.5 | 12.2 ± 9.8 | 12.7 ± 10.9 | 0.27 |
| Hospitalizations in past year | 24 (19.2%) | 9 (20.5%) | 15 (18.5%) | 0.07 |
| ER in last year in past year | 49 (39.2%) | 21 (47.7%) | 28 (34.6%) | 2.07 |
| Primary care (2 or more visits in past year) | 118 (94.4%) | 41 (93.2%) | 77 (95.1%) | 0.19 |
| Drug use and treatment | ||||
| Crack cocaine or powder cocaine use in past year | 33 (26.4%) | 12 (27.3%) | 21 (25.9%) | 0.03 |
| Methamphetamine use in past year | 17 (13.6%) | 8 (18.2%) | 9 (11.1%) | 1.21 |
| Any injection drug use in past year | 61 (48.8%) | 24 (54.6%) | 37 (45.7%) | 0.90 |
| On methadone therapy in past year | 25 (20.0%) | 7 (15.91%) | 18 (22.22%) | 0.71 |
| Incarceration | ||||
| Incarceration in past year | 11 (8.8%) | 4 (9.1%) | 7 (8.6%) | 0.01 |
| Enrolled time | ||||
| Mean years (±SD) | 4.5 (3.1) | 5.2 (3.1) | 4.1 (3.1) | −1.90 |
a
Test statistics used were chi-square for frequencies, Student's t-test for means, and Wilcoxon Z tests for medians used to compare participants who were covered by Medicare Part D with those with other prescription drug coverage.
*
P<.05,
**
P<.01